Rein Therapeutics's total assets for Q3 2024 were $104.22M, a decrease of -4.74% from the previous quarter. RNTX total liabilities were $53.99M for the fiscal quarter, a 544.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.